Table 2.
The intersection of top 50 drugs by activity (Method 1) and connectivity (Method 2) scores on FOXM1 pathway.
Drug name | Dose (µM) | Na | Rank by | Activity score (Method 1) | Connectivity score (Method 2) | |||
---|---|---|---|---|---|---|---|---|
Activity score difference (ASd)b | Connectivity score | Treatment (ASt) | Control (ASc) | Difference (ASd) | ||||
5109870 | 25 | 1 | 1 | 10 | −8.57 | 1.59 | −10.16 | −0.66 |
MG-132 | 21 | 1 | 2 | 1 | −4.45 | 1.97 | −6.42 | −1 |
MG-262 | 0.1 | 1 | 4 | 3 | −2.95 | 1.79 | −4.74 | −0.83 |
Celastrol | 2.5 | 1 | 5 | 7 | −2.99 | 1.59 | −4.58 | −0.72 |
Resveratrol | 50 | 2 | 6 | 8 | 0.92 | 5.2 | −4.28 | −0.7 |
Ciclopirox | 15 | 2 | 7 | 37 | −2.45 | 1.53 | −3.98 | −0.59 |
Pyrvinium | 3.4 | 2 | 11 | 2 | −1.85 | 1.56 | −3.41 | −0.84 |
Emetine | 7.2 | 2 | 13 | 14 | −1.37 | 1.71 | −3.08 | −0.63 |
15-delta prostaglandin J2 | 10 | 8 | 14 | 11 | −1.18 | 1.73 | −2.91 | −0.66 |
Cephaeline | 6 | 3 | 15 | 32 | −0.95 | 1.96 | −2.91 | −0.6 |
Puromycin | 7.4 | 2 | 16 | 17 | −0.94 | 1.89 | −2.84 | −0.62 |
Parthenolide | 16.2 | 2 | 23 | 18 | −1.43 | 1.03 | −2.46 | −0.62 |
Azacitidine | 16.4 | 2 | 24 | 49 | −0.87 | 1.53 | −2.39 | −0.57 |
Cycloheximide | 14.2 | 2 | 28 | 45 | −0.3 | 2 | −2.29 | −0.57 |
Astemizole | 8.8 | 2 | 29 | 27 | 0.04 | 2.3 | −2.26 | −0.6 |
5224221 | 12 | 2 | 36 | 25 | −1.42 | 0.61 | −2.03 | −0.6 |
Scriptaid | 10 | 1 | 42 | 20 | 1.32 | 3.29 | −1.97 | −0.62 |
Ouabain | 5.4 | 2 | 43 | 30 | −0.34 | 1.63 | −1.97 | −0.6 |
Bepridil | 10 | 2 | 49 | 13 | 0.12 | 2 | −1.88 | −0.63 |
aThe number of experiments.
bActivity difference (ASd) = activity score in treatment (ASt) − activity score in control (ASc).